View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. MediSapiens
15 January 2018

MediSapiens Joins Pistoia Alliance to Collaborate with Life Science Peers on New Innovations

MediSapiens has collaborated with The Pistoia Alliance, a global, non-profit alliance of life science companies, vendors, publishers and academic groups.

Founded in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer, the alliance has nearly 70 paying member organisations.

Some of the alliance’s key activities are pre-competitive projects, where partners join their forces to establish best practices and technology pilots. Successful initiatives have included The HELM Project and the launch of the Chemical Safety Library Service.

President of The Pistoia Alliance Dr. Steve Arlington said: “We are very pleased to welcome MediSapiens into The Pistoia Alliance, and look forward to working with them to achieve our goal of lowering barriers to innovation in the life science industry.

“The world of life sciences research & Development (R&D) continues to change rapidly and sharing, partnering and collaborating will be essential to increased innovation. As our membership continues to grow, our projects and initiatives will be vital in fostering this collaborative mindset and leading to new breakthroughs.”

With nearly a decade of experience working in the life science software industry, MediSapiens will be able to offer its expertise in scientific, technological and bioinformatics developments to The Pistoia Alliance’s innovation projects. By joining the alliance, MediSapiens will have the opportunity to collaborate with industry peers and contribute to the development of the worldwide research community.

Chief scientific officer of MediSapiens Henrik Edgren said: “We are excited to be a part of The Pistoia Alliance and we look forward to being an active member of the workgroups.

“Joining the Pistoia Alliance enables us to follow and influence the latest developments in data sharing and efficient collaboration in life sciences, for instance in our work with implementing ontologies effectively.”

This document demonstrates an example Medisapiens report. It focuses on the gene PTPRK.
Identifying fusion genes from paired-end ribonucleic acid (rna) sequencing (rna-seq) data has the advantage that only expressed fusion genes will be found.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology